[e-drug] Report on SF & diverted issues with COVID-19 vaccines

E-DRUG: Report on SF & diverted issues with COVID-19 vaccines
-----------------------------------------------------------------

Dear colleagues,

We are writing to share the first issue of the Medical Product Quality
Report - COVID-19 Vaccine Issues. With the continued global vaccine roll
out, we have worked on a report that lists incidents and problems with
COVID-19 vaccines quality, diversions, thefts and scams. This report is
distinct from the monthly Medical Product Quality Report - COVID-19 issues
that covers incidents related to a variety of medical products.

https://www.iddo.org/mq/research/medical-product-quality-reports

We plan to regularly update the COVID-19 vaccine report, with the aim to
aid national medicine regulators, international organizations, vaccine
manufacturers and distributors and civil society by summarising the current
public domain literature, to inform action and policy and encourage
urgently needed joined-up interventions to reduce the risk of substandard
and falsified COVID-19 vaccines on global public health.

Data in the report are from the scientific literature, public
alerts/warnings, and lay press. We included especially information
from our Medicine Quality Monitoring Globe - available at:
https://www.iddo.org/news/first-global-tool-track-news-reports-substandard-and-falsified-medical-products-live

The MQM Globe, is a free-to-use online tool that maps news reports
worldwide of SF medical products.

The report can be downloaded from the following link under the heading
GLOBAL LITERATURE ON SF COVID-19 VACCINES:
https://www.tropmedres.ac/research-areas/medicine-quality/medicine-quality

Any remarks or additions to content are greatly appreciated
please write to
medicinequality@iddo.org

We would be delighted if you could disseminate this information within your network.

Very best wishes,

Kerlijn Van Assche, Celine Caillet, Paul N Newton

Medicine Quality Research Group, Infectious Diseases Data Observatory
(IDDO) & Mahidol Oxford Research Unit (MORU), Centre for Tropical Medicine
& Global Health, University of Oxford, Oxford, UK
Kerlijn Van Assche <kerlijn.vanassche@iddo.org>